Positive impact of pre-stroke surgery on survival following transient focal ischemia in hypertensive rats  by Ord, Emily N.J. et al.
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 i  g  h  l  i g  h  t  s
Methodological  reﬁnement  improved  survival  from  stroke  in hypertensive  rats.
Post-stroke  associated  weight  loss is  reduced  in  animals  with  pre-stroke  surgery.
Surviving  animals  (±pre-stroke  surgery)  have  equivalent  infarct  volumes.
Surviving  animals  (±pre-stroke  surgery)  show  same  neurological  deﬁcit  severity.
Important  implications  for  animal  welfare/groups  sizes  required  for  stroke  studies.
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a  b  s  t  r  a  c  t
We  describe  a  positive  inﬂuence  of  pre-stroke  surgery  on  recovery  and  survival  in a commonly  used
experimental  stroke  model.  Two  groups  of  male,  stroke-prone  spontaneously  hypertensive  rats  (SHRSPs)
underwent  transient  middle  cerebral  artery  occlusion  (tMCAO).  Group  1 underwent  the  procedure  with-
out  any  prior  intervention  whilst  group  2 had  an  additional  general  anaesthetic  6 days  prior  to  tMCAO
for  a cranial  burrhole  and  durotomy.  Post-stroke  recovery  was  assessed  using  a  32 point  neurological
deﬁcit  score  and tapered  beam  walk  and  infarct  volume  determined  from  haematoxylin–eosin  stained
sections.  In  group  2 survival  was  92%  (n = 12) versus  67%  in  group  1  (n =  18). In  addition,  post-tMCAO
associated  weight  loss  was  signiﬁcantly  reduced  in group  2.  There  was  no  signiﬁcant  difference  between
3
urvival
ransient focal ischemia
the  two  groups  in  experimental  outcomes:  infarct  volume  (Group  1  317  ±  18.6 mm versus  Group  2
332 ±  20.4  mm3),  and  serial  (day 0–14  post-tMCAO)  neurological  deﬁcit  scores  and  tapered-beam  walk
test.  Drilling  a cranial  burrhole  under  general  anaesthesia  prior to tMCAO  in  SHRSP  reduced  mortality
and  gave  rise  to infarct  volumes  and  neurological  deﬁcits  similar  to  those  recorded  in  surviving  Group  1
animals.  This  methodological  reﬁnement  has  signiﬁcant  implications  for  animal  welfare  and  group sizes
 studrequired  for  intervention
. Introduction
The need for robust pre-clinical models of stroke is well
ecognised given the poor translation from bench to bedside for
troke interventions. Often, pre-clinical studies fail to consider co-
orbidities associated with stroke clinical presentation. The most
igniﬁcant risk factors (hypertension, current smoking, abdominal
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obesity, diet and physical inactivity) account for 80% of the global
risk for stroke with self-reported history of hypertension being the
strongest of these risk factors (O’Donnell et al., 2010). The revised
STAIR guidelines (Fisher et al., 2009) highlighted the need to include
co-morbidities in pre-clinical stroke models to better model the
clinical situation. A recent review cited that of 493 drugs tested
in experimental stroke models only 84 were tested in hyperten-
sive animals (generally the spontaneously hypertensive rat, SHR)
(Howells et al., 2010). However, with the inclusion of risk factors
such as ageing, hypertension and diabetes there is an increased risk
Open access under CC BY-NC-ND license.of mortality, particularly in closed skull models using an intralumi-
nal ﬁlament and beyond the 24 h recovery period commonly used in
pre-clinical studies (Spratt et al., 2006; Rewell et al., 2010). Follow-
ing tMCAO in rats, however, the infarct has been shown to evolve
3 science Methods 211 (2012) 305– 308
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Fig. 1. Determination of ﬁnal infarct volume. Infarct volume (mm3) in SHRSP was06 E.N.J. Ord et al. / Journal of Neuro
eyond 24 h out to 48–72 h (Li et al., 2000; Neumann-Haefelin et al.,
000), therefore, when assessing potential new therapeutic strate-
ies it is important to set an experimental endpoint at or beyond
he time when infarct is ﬁnal to ensure efﬁcacy is maintained and
hat infarct evolution is not simply delayed. Here, we describe a
re-stroke surgical procedure in the spontaneously hypertensive
troke prone rat (SHRSP) which has a positive impact on animal
elfare and survival from a subsequent (6 days later) tMCAO. The
esulting infarct and neurological deﬁcit are reproducible and sim-
lar in size to outcome in surviving rats exposed to tMCAO without
re-surgery. Improved survival with this procedure was  identiﬁed
uring a prior study involving pre-stroke central administration of
 viral vector which involved a general anaesthetic, burrhole and
urotomy to stereotaxically inject the virus 6 days prior to tMCAO
Ord et al., unpublished results).
. Materials and methods
.1. Animals
Sixteen week old, male, SHRSP (270–310 g) were maintained
in-house” by brother–sister mating. The animals were kept in
tandard polycarbonate cages in small groups of two  to three,
ith ad libitum access to rodent chow (RM1 expanded diet, SDS,
ngland) and untreated tap water. All studies were carried out in
ccordance with the Animals Scientiﬁc Procedures Act 1986 and
ere approved by the University of Glasgow’s Ethics Review Com-
ittee. In total, 30 animals were used with power calculations used
o determine group sizes required to detect statistically signiﬁcant
ifferences.
.2. Tail cuff plethysmography
Systolic blood pressure monitoring was carried out by non-
nvasive computerised tail-cuff, based on the plethysmographic
ethod. Brieﬂy, rats were preheated to ∼39 ◦C for ∼20 min  and
estrained by wrapping in a surgical drape, before a pneumatic
ressure sensor was attached to the tail distal to a pneumatic
ressure cuff, both under the control of a Programmed Electro-
phygmomanometer. Systolic blood pressure values from each
nimal were determined from the mean of a minimum of six sepa-
ate indirect pressure measurements. Animals had been previously
abituated to the procedure before actual measurements were
aken.
.3. Surgical procedures
All surgical interventions were performed by the same surgeon
nd at the same time of day. Animals were randomly allocated to
roup 1 or 2. Rats were anaesthetised (2.5–3% isoﬂurane in oxy-
en) and artiﬁcially ventilated. Group 1 (n = 18) underwent tMCAO
y advancing a silicone-coated monoﬁlament (Doccol Corporation,
SA) through the internal carotid artery to block the MCA  for 45 min
efore reperfusion (total anaesthetic exposure <90 min). Group 2
nimals (n = 12) were anaesthetised, positioned in a stereotactic
rame and a 1 mm diameter burrhole made 6 days prior to tMCAO.
 24G Hamilton syringe needle was used to pierce the dura before
ealing the burrhole with dental cement (Prontolute; Wright Cot-
erell, UK). The duration of anaesthesia for this additional procedure
as typically 30 min, not exceeding 40 min  on any occasion.
.4. Infarct volumeFourteen days following tMCAO, rats (n = 14) were killed
y transcardiac perfusion ﬁxation. Formalin-ﬁxed, parafﬁn-
mbedded tissue sections (6 m)  were deparafﬁnised, rehydrateddetermined on day 14 following tMCAO from H&E stained sections over 8 coronal
levels. Each data point represents an individual animal, horizontal bar represents
mean.
and stained with haematoxylin and eosin and infarct volume
assessed over 8 coronal levels. Brains from remaining rats (n = 9)
were used for biochemical analyses. Infarct measures were made
blinded to group allocation.
2.5. Neurological outcome
Neurological outcome was  determined before stroke surgery
and at 1, 2, 3, 7, 10 and 14 days post-tMCAO from (a) number of foot-
falls recorded as rats traversed a 130 cm tapered beam and (b) using
a battery of 10 tests to provide an overall neurological score (max-
imum score 32). Where possible, measures of neurological deﬁcit
were assessed blinded to group allocation.
2.6. Statistics
Data are presented as mean ± s.e.m. Groups were compared
using a one-way ANOVA with Bonferroni’s correction for multi-
ple comparisons. Survival rates were compared using Fisher’s exact
test. A p value of <0.05 was  deemed statistically signiﬁcant.
3. Results
Survival was 67% in group 1 (12 out of 18 rats, no pre-stroke
surgery) versus 92% in group 2 (11 out of 12 rats with pre-stroke
surgery). Mortality occurred within 24–48 h of stroke onset and
was attributed to the severity of the stroke, size of infarct and asso-
ciated brain swelling and increased intracranial pressure resulting
in depression of the cardiovascular and respiratory centres in the
brainstem. Brain haemorrhage was not recorded in any instance.
There was no signiﬁcant difference in conscious systolic blood pres-
sure [group 1 versus group 2 measured 3–4 days prior to tMCAO
(baseline; mm Hg): 175.6 ± 5.4 versus 174.7 ± 5.0; at sacriﬁce:
172.7 ± 3.8 versus 177.9 ± 4.5] or pre-stroke body weight [group
1 versus group 2 (g): 282.2 ± 3.4 versus 272 ± 4.9] between groups.
However, rats in group 2 had a lower weight loss associated with
the stroke than group 1 rats indicative of a faster return to regular
feeding patterns; weight loss from pre-stroke to sacriﬁce (+14 days)
was group 1 31.1 ± 2.4 g versus group 2 18.3 ± 1.1 g; p = 0.0005. Final
infarct volume was not signiﬁcantly different between the groups
[group 1 versus group 2 (mm3) 317 ± 18.6 versus 332 ± 20.4; Fig. 1].
Oedema was not measured as histological processing of the brains
involved dehydration and, as such, assessment of brain swelling
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Fig. 2. Assessment of neurological deﬁcit following tMCAO. (A) 32-point neurological score measured general condition, righting reﬂex, grip strength, paw placement, circling,
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or  both ipsi- and contralateral side and expressed as a percentage of all foot-steps
nd  7, 10 and 14; group 1 (n = 5), group 2 (n = 5) post-tMCAO (not all animals assess
ould be ﬂawed. Furthermore, by day 14 post-tMCAO oedema or
welling associated with stroke would not persist. Longitudinal
ssessment of neurological score to day 14 post-tMCAO (Fig. 2A)
nd forelimb and hindlimb impairment were not signiﬁcantly dif-
erent between animals in groups 1 and 2 (Fig. 2B). Furthermore,
he variation in the number of footfaults made on the tapered beam
alk test was  less in animals in group 2 versus group 1.
. Discussion
Pre-stroke general anaesthesia and cranial burrhole surgery
mproved survival in SHRSP exposed to 45 min  tMCAO and reduced
ost-tMCAO associated weight loss. Systolic blood pressure, infarct
olumes and neurological deﬁcits were similar to surviving ani-
als from the no pre-stroke surgery group. This experimental
eﬁnement improves the utility, animal welfare and validity of pre-
linical stroke models exhibiting stroke-associated co-morbidities,
uch as hypertension and has been supported by the regulatory
uthorities governing pre-clinical studies. The reduced mortality
ate directly addresses the requirement to implement the 3R’s
reﬁnement, reduction, replacement) in stroke research whilstment on tapered beam was tracked, footfalls onto an under-hanging ledge recorded
. Measures assessed at baseline and days 1, 2, 3; group 1 (n = 12), group 2 (n = 11)
 for neurological deﬁcit at later times). Group data presented are mean ± s.e.m.
allowing the inclusion of co-morbidity models, in line with STAIR
(Fisher et al., 2009).
Consideration of stroke risk factors is often overlooked in pre-
clinical studies with most using healthy, young rats (Howells et al.,
2010). In addition to the animal model used, the stroke models
differ with both permanent and transient MCAO available. While
the intraluminal ﬁlament model used here is the most commonly
used stroke model (both permanent and transient MCAO) the main
disadvantages are reproducibility and higher mortality in nor-
motensive or hypertensive rats. Models requiring craniectomy and
durotomy have low or absent mortality (reviewed in Macrae, 2011).
Successful experimental reﬁnements have been described for the
intraluminal ﬁlament model using aged, hypertensive and diabetic
animals through modiﬁcation of the occluding ﬁlament used for
a 2 h tMCAO resulting in a signiﬁcant improvement in both suc-
cessful stroke induction and a reduction in mortality (Spratt et al.,
2006). Furthermore, modiﬁcation of the dosing regime in aged ani-
mals for the induction of diabetes with streptozotocin improved
survival thus allowing induction of tMCAO on this background
(Rewell et al., 2010). In both cases, outcome (infarct volume) was
assessed 24 h post-tMCAO. However, ﬁnal infarct volume in rat
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MCAO models can continue to evolve out to 48–72 h with a con-
omitant increase in brain oedema and higher mortality (Li et al.,
000; Neumann-Haefelin et al., 2000). The technical modiﬁcation
escribed here allowed outcome measures to be determined 14
ays post-tMCAO, providing serial data on functional outcome and
nal infarct. Furthermore, the extent of post-tMCAO associated
eight loss was signiﬁcantly reduced in those animals that under-
ent pre-stroke surgery suggesting an overall improvement in
nimal welfare in this group with a quicker return to regular eating
atterns. Together, these demonstrate both a reﬁnement in the pro-
edure with a concomitant reduction in mortality or reduction in the
umber of animals required for a study through an improved sur-
ival so addressing 2 of the 3Rs of animal experimentation. Given
hat the procedural associated mortality with normotensive and
ypertensive animals involves the same mechanisms, we specu-
ate that the experimental reﬁnement described here will reduce
ortality for normotensive animals also when closed skull stroke
odels are used.
Factors which could potentially explain the reduced mortal-
ty include pre-stroke general anaesthesia (pre-conditioning), the
urrhole itself and durotomy. Isoﬂurane preconditioning has been
escribed to improve neurological outcome following tMCAO in
ats (Kapinya et al., 2002; Li and Zuo, 2009) however, this effect
as only described when experimental stroke was induced up to
8 h after the preconditioning stimulus [30 min  (Li and Zuo, 2009)
r 3 h (Kapinya et al., 2002) exposure to isoﬂurane anaesthesia].
n the current study, animals in group 2 were exposed to 30 min
soﬂurane 6 days before tMCAO, a sustained preconditioning effect
or such a prolonged period between the initial isoﬂurane expo-
ure and focal cerebral ischemia has, to our knowledge, not been
escribed (reviewed in Kitano et al., 2007). Sustained protection
as been reported up to 8 weeks after repeated hypoxic precon-
itioning in mice (Stowe et al., 2011) although the mechanism for
his sustained protection involves mechanisms distinct and differ-
nt to that implicated for inhalation anaesthetic preconditioning.
ence, it seems unlikely that an isoﬂurane preconditioning effect
ould be responsible for the improved survival in group 2, all the
ore because no improvement in neurological recovery or reduc-
ion in infarct volume was detected in surviving animals, which is in
ontrast to previous studies (Kapinya et al., 2002; Li and Zuo, 2009).
In humans with severe MCA  ischemic strokes there is often
 life-threatening, space-occupying brain oedema and this has
een associated with mortality rates of up to 80% (Bardutzky and
chwab, 2007). In clinical studies, reducing intracranial pressure
hrough procedures such as decompressive craniectomy reduced
troke mortality by 50% at 1 year versus best medical intervention
Vahedi et al., 2007) and a more recent review has concluded that
he practice of opening the cranial vault and the dura for surgi-
al decompression of cerebral oedema in acute ischemic stroke is
till the treatment of choice in some patients (Cruz-Flores et al.,
012). By comparison, the cranial burrhole in the present study
as signiﬁcantly smaller than any surgical hemicraniectomy and
as immediately sealed with dental cement to reduce the risk of
nfection. However, in humans, it has been shown that a cran-
otomy with mere durotomy via dural incisions can have the same
eneﬁcial effect of intracranial decompression following traumatic
rain injuries as does the more invasive practice of craniectomy
nd duroplasty (Burger et al., 2008). Opening of the dura is crucial
or effective reduction of intracranial pressure. Moreover, drainage
f even small volumes of CSF can dramatically reduce increased
CP caused by oedema (Singhi and Tiwari, 2009). Hence, it is pos-
ible that the beneﬁcial effect on survival shown in our study was direct result of the durotomy which might have enabled excess
erebrospinal ﬂuid to drain away as oedema and brain swelling
volved in the early hours to days after tMCAO. Further studies
ould be performed to elucidate the exact mechanism behind thee Methods 211 (2012) 305– 308
improved survival and recovery shown in our report but, for ethical
reasons, we do not think they are warranted. We have been able to
ascertain, by using the described technique in subsequent studies,
that the beneﬁcial effects of the pre-stroke surgery are reduced if
it is performed more than 7 days before tMCAO surgery.
In conclusion, we describe a methodological reﬁnement to the
tMCAO procedure which reduced mortality and post-tMCAO asso-
ciated weight loss in SHRSP, an animal model exhibiting many
of the co-morbidities associated with stroke clinically (hyperten-
sion, altered glucose handling and increased basal inﬂammatory
status). Further, infarct size and neurological deﬁcit were not dif-
ferent to values recorded in group 1 animals which survived the
stroke surgery. As such, we  believe this reﬁnement can easily be
employed by pre-clinical stroke researchers to improve survival
when closed skull experimental stroke models are used, particu-
larly when using hypertensive rats, thus reducing the total number
of animals required to complete a study.
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